Canagliflozin alleviates progestin resistance by suppressing RARĪ²/CRABP2 signaling in THRB knockout endometrial cancer cells [PDF]
Frontiers in PharmacologyIntroductionProgestin resistance has emerged as a significant barrier to the conservative management of endometrial cancer (EC). The mechanisms underlying progestin resistance in endocrine therapy remain incompletely understood.
Ye Yang +13 more
doaj +2 more sources
Early postpartum luteal function after treatment with progestin and(or) gonadotropin-releasing hormone in dairy cattle [PDF]
, 1988 Progestin (NorgestometĀ®) and(or) repeated low-dose infusions of GnRH (Cystorelin@) influenced the lifespan of the first corpus luteum after an induced ovulation. Holstein cows (n=32) were assigned at calving to four groups. Cows were treated with blank
Mee, M.O., Stevenson, Jeffrey S.
core +4 more sources
Fertility-sparing treatment for patients with endometrial cancer: a bibliometric analysis from 2000 to 2024 [PDF]
Frontiers in OncologyIntroductionThe rising global incidence of endometrial cancer (EC), particularly among younger patients, has established fertility-sparing treatment as a critical focus in gynecological and reproductive medicine.
Yue Gao +4 more
doaj +2 more sources
Dharma Raflesia, 2022 Post partum atau masa nifas adalah masa setelah keluarnya plasenta sampai alat-alat reproduksi pulih seperti sebelum hamil berlangsung 6 minggu. Pil progestin merupakan alat kontrasepsi yang aman untuk ibu post partum.
Dara Himalaya, Deni Maryani
doaj +1 more source
Verteporfin reverses progestin resistance through YAP/TAZ-PI3K-Akt pathway in endometrial carcinoma
Cell Death Discovery, 2023 Progestin resistance is a problem for patients with endometrial carcinoma (EC) who require conservative treatment with progestin, and its underlying mechanisms remain unclear. YAP and TAZ (YAP/TAZ), downstream transcription coactivators of Hippo pathway,
Lina Wei +9 more
doaj +1 more source
Frontiers in Endocrinology, 2023 ObjectiveProgestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC).
Fengping Shao, Yinguang Li, Yunhe Zhao
doaj +1 more source
Comparison of the efficacy of altrenogest versus transdermal progestin patches on estrus synchronization and ovulation in mares [PDF]
Veterinary World, 2023 Background and Aim: The adhesive progestin patch was investigated for estrus synchronization in mares because this method is convenient and safe in other species.
Jatuporn Kajaysri +1 more
doaj +1 more source
Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study. [PDF]
PLoS ONE, 2017 To estimate associations of progestin-only contraceptives with persistent pelvic girdle pain 18 months after delivery.Prospective population based cohort study during the years 2003-2011.
Elisabeth Krefting Bjelland +6 more
doaj +1 more source
Frontiers in Genetics, 2022 Objective: The aim of this study was to establish predictive models based on the molecular profiles of endometrial lesions, which might help identify progestin-insensitive endometrial atypical hyperplasia (EAH) or endometrioid endometrial cancer (EEC ...
Jia-Li Hu +11 more
doaj +1 more source
Vitamin D and Mitosis Evaluation in Endometriosis: A Step toward Discovering the Connection?
Biomedicines, 2023 (1) Background: The effects of serum vitamin D levels, the vitamin D receptor (VDR), and phosphohistone H3 (PHH3) in endometriosis were investigated in two cohorts of women with this pathology: those receiving hormonal treatment and those without ...
Daniela Roxana Matasariu +9 more
doaj +1 more source